Clinical Trial Update: A Study to Find Out Whether BI 765423 Has an Effect on Lung Function in People With Idiopathic Pulmonary Fibrosis (IPF) With or Without Standard Treatment [Phase 2]

View source ↗

Summary

This update describes a Phase 2 clinical trial evaluating BI 765423 for its effect on lung function in idiopathic pulmonary fibrosis, with or without standard t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Pulmonary Fibrosis

Drugs mentioned

• BI 765423

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Idiopathic Pulmonary Fibrosis | Phase 2 | Status: RECRUITING